Metraipolis › archive › dc_f55e52ecea8b

Coverage, Timing, Safety, and Determinants of Neonatal Intensive Care Unit Admission in Newborns Receiving Nirsevimab Prophylaxis for Respiratory Syncytial… — Europe PMC PMID:42654750

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42654750
DOI
10.3390/pathogens15080813
License (as archived)
solo-consultazione
Archived
2026-10-17T06:21:08.175Z
SHA-256 of the archived text
4746b2f1b59224f662ae44354523c84e6b84e2dd6e9c76ce6e9e09fd728e4a78
Stable URL of this page
https://metraipolis.com/documento/dc_f55e52ecea8b

How to cite

Coverage, Timing, Safety, and Determinants of Neonatal Intensive Care Unit Admission in Newborns Receiving Nirsevimab Prophylaxis for Respiratory Syncytial… — Europe PMC PMID:42654750 — Europe PMC (en), https://europepmc.org/article/MED/42654750 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f55e52ecea8b (Metraipolis archive dc_f55e52ecea8b, sha256 4746b2f1b59224f662ae44354523c84e6b84e2dd6e9c76ce6e9e09fd728e4a78)
BibTeX
@misc{dcf55e52ecea8b,
  title = {Coverage, Timing, Safety, and Determinants of Neonatal Intensive Care Unit Admission in Newborns Receiving Nirsevimab Prophylaxis for Respiratory Syncytial… — Europe PMC PMID:42654750},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42654750},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f55e52ecea8b; sha256 4746b2f1b59224f662ae44354523c84e6b84e2dd6e9c76ce6e9e09fd728e4a78},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42654750. Agents can read the archived copy with the MCP tool read_document.